Atlas Trials

GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma

Clinical trial NCT00893477 · UNKNOWN

Trial details

NCT number
NCT00893477
Sponsor
French Innovative Leukemia Organisation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2009-03-01
Primary completion
2011-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.